PharmiWeb.com - Global Pharma News & Resources
03-Apr-2019

Dermapharm continues its profitable growth in 2018

DGAP-News: Dermapharm Holding SE / Key word(s): Preliminary Results


The issuer is solely responsible for the content of this announcement.




03.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Phone: +49 (0)89 64 86-0
E-mail: ir@dermapharm.de
Internet: ir.dermapharm.de
ISIN: DE000A2GS5D8
WKN: A2GS5D
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange
EQS News ID: 795053

 
End of News DGAP News Service

Editor Details

Last Updated: 03-Apr-2019